1. Home
  2. STN vs RGEN Comparison

STN vs RGEN Comparison

Compare STN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STN
  • RGEN
  • Stock Information
  • Founded
  • STN 1954
  • RGEN 1981
  • Country
  • STN Canada
  • RGEN United States
  • Employees
  • STN N/A
  • RGEN N/A
  • Industry
  • STN Military/Government/Technical
  • RGEN Medical/Dental Instruments
  • Sector
  • STN Consumer Discretionary
  • RGEN Health Care
  • Exchange
  • STN Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • STN 12.0B
  • RGEN 8.0B
  • IPO Year
  • STN N/A
  • RGEN N/A
  • Fundamental
  • Price
  • STN $110.39
  • RGEN $127.47
  • Analyst Decision
  • STN
  • RGEN Buy
  • Analyst Count
  • STN 0
  • RGEN 12
  • Target Price
  • STN N/A
  • RGEN $170.40
  • AVG Volume (30 Days)
  • STN 173.6K
  • RGEN 685.0K
  • Earning Date
  • STN 08-06-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • STN 0.41%
  • RGEN N/A
  • EPS Growth
  • STN 14.85
  • RGEN N/A
  • EPS
  • STN 2.34
  • RGEN N/A
  • Revenue
  • STN $4,208,787,002.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • STN $11.87
  • RGEN $13.93
  • Revenue Next Year
  • STN $7.82
  • RGEN $14.35
  • P/E Ratio
  • STN $47.08
  • RGEN N/A
  • Revenue Growth
  • STN 16.16
  • RGEN 4.88
  • 52 Week Low
  • STN $73.18
  • RGEN $102.97
  • 52 Week High
  • STN $110.39
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • STN 67.66
  • RGEN 54.11
  • Support Level
  • STN $107.28
  • RGEN $121.44
  • Resistance Level
  • STN $110.17
  • RGEN $131.43
  • Average True Range (ATR)
  • STN 1.38
  • RGEN 4.47
  • MACD
  • STN -0.27
  • RGEN 0.61
  • Stochastic Oscillator
  • STN 82.11
  • RGEN 74.57

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: